Notice Number: NOT-HL-17-490
Release Date: March 6, 2017
Estimated Publication Date of Announcement: Summer 2017
First Estimated Application Due Date: Fall 2017
Earliest Estimated Award Date: Spring/Summer 2018
Earliest Estimated Start Date: Spring/Summer 2018
National Heart, Lung, and Blood Institute (NHLBI)
The National Heart, Lung, and Blood Institute (NHLBI) intends to publish a Funding Opportunity Announcement (FOA) to establish new prospective epidemiology cohort studies that will examine heart, lung, blood, and/or sleep phenotypes. The NHLBI is interested in applications that will address questions relevant to the NHLBI mission, address gaps in the NHLBI's portfolio of epidemiology cohorts, and should align with the Institute's Strategic Vision (https://www.nhlbi.nih.gov/about/documents/strategic-vision).
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in Summer 2017 with an expected application due date in Fall 2017.
This FOA will utilize the U01 activity code. Details of the planned FOA are provided below.
The NHLBI is looking to fund new, investigator-initiated epidemiological cohort studies that are designed to answer a breadth of scientific questions related to heart, lung, blood, and/or sleep diseases, disorders, and phenotypes. The FOA will encourage applications to investigate innovative hypotheses, including detailed baseline data collection from at least 2000 cohort participants, as well as support for study infrastructure, biospecimen storage, and data analysis for these new cohorts. The goal of this initiative is to encourage creative and innovative research; as such, applications should propose studies investigating hypotheses not addressable in the large cohorts currently funded by the NHLBI.
APPLICATIONS ARE NOT BEING SOLICITED AT THIS TIME.
Please direct all inquiries to:
Mollie Minear, Ph.D.
National Heart, Lung, and Blood Institute